A New Option Reducing the Burden of Facelifts… SH Plastic Surgery Introduces Renuvion

[mdtoday = Reporter Kim Mi-kyung] How to bridge the gap between effectiveness and burden is emerging as a new hot topic among consumers considering facial lifting. This is because while non-surgical lifting offers fast recovery, it has limitations in the durability and scope of its effects; on the other hand, while a surgical facelift can provide more definitive improvements, it carries a significant burden regarding incision scars and recovery time.

Amid this context, SH Plastic Surgery announced that it has introduced Renuvion, a helium plasma-based device, as an alternative to facelifts.

Dr. Kim Sung-hoon, Director of SH Plastic Surgery, explained, "In actual consultations, there are quite a few patients who find a full facelift burdensome, yet are in a state where it is difficult to be satisfied with existing radiofrequency or ultrasound lifting. Renuvion is a device introduced as a realistic alternative for this patient group in the intermediate stage."

▲ Director Kim Sung-hoon (Photo provided by SH Plastic Surgery)

Renuvion is a technology that rapidly contracts internal skin tissue using helium plasma energy. It is characterized by reaching high energy levels within a short time and then immediately cooling down, inducing tissue contraction and tightening effects while minimizing damage to surrounding tissues.

Director Kim stated, "Even in cases where existing non-surgical lifting had limitations in improving the jawline, neck, and midface sagging, more structural changes can be expected through Renuvion. In particular, it can serve as an option for consumers who have been hesitating due to the incision scars or recovery burden of a facelift."

A facelift is a method that directly removes sagging skin through incisions, offering definitive effects, but it can come with the burden of recovery time and incision scars around the ears or scalp area. In contrast, Renuvion is performed through minimal incisions or micro-approaches, resulting in relatively less concern over visible scars and a comparatively shorter recovery period.

The clinic explained, "Renuvion is not simply a concept of pulling the skin surface, but a method that induces the contraction and elasticity recovery of the fibrous tissue inside the skin. Rather than completely replacing a facelift, it holds significance as a 'pre-facelift stage' or a 'facelift alternative.'"

Another feature of Renuvion is that it has few restrictions on treatment areas. It can be applied not only to the face but also to various body parts wherever skin and fibrous tissue exist. According to SH Plastic Surgery, for facial areas, it is applied to forehead wrinkles, midface sagging, upper eyelid wrinkles, lower eyelid sagging and fine lines around the eyes, wrinkles around the mouth and lips, philtrum wrinkles, neck wrinkles, submental (under the chin) sagging, and jawline sagging.

Other body parts: It can be applied to wrinkles on the back of the hands, wrinkles above the knees, sagging abdominal skin, loose skin after liposuction, inelastic skin on the thighs, and sagging skin on the upper arms.

The clinic added, "The application method and scope may vary depending on the skin thickness and degree of sagging in each area, and decisions must be made through a consultation with medical staff."

Regarding the criteria for choosing a procedure, Director Kim Sung-hoon emphasized, "Mild sagging can be sufficiently addressed with existing non-surgical lifting, while severe sagging may still require a facelift. What is important is not the procedure itself, but choosing the most suitable method by comprehensively considering the patient's skin condition, degree of sagging, and recovery circumstances."

He continued to advise, "If a facelift felt too burdensome, it is advisable to check whether Renuvion is a suitable option for you through an in-depth consultation at a clinic that has introduced it."

Medical Today Reporter Kim Mi-kyung (sallykim0113@mdtoday.co.kr)

Source: Medical Today https://www.mdtoday.co.kr/news/articleView.html?idxno=515366